Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display (2023)
- Authors:
- USP affiliated authors: SETUBAL, JOÃO CARLOS - IQ ; CUNHA NETO, EDECIO - FM ; SABINO, ESTER CERDEIRA - FM ; GIORDANO, RICARDO JOSÉ - IQ
- Unidades: IQ; FM
- DOI: 10.1371/journal.pntd.0011019
- Subjects: DOENÇA DE CHAGAS; GENOMAS; ANTICORPOS; TRYPANOSOMA CRUZI
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2023
- Source:
- Título do periódico: Plos Neglected Tropical Diseases
- ISSN: 1935-2735
- Volume/Número/Paginação/Ano: v. 17, n. 1, p. 1-20 art. e0011019, 2023
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CARNERO, Luis Antonio Rodriguez et al. Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display. Plos Neglected Tropical Diseases, v. 17, n. 1, p. 1-20 art. e0011019, 2023Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0011019. Acesso em: 10 jun. 2024. -
APA
Carnero, L. A. R., Kuramoto, A., Oliveira, L. C. de, Monteiro, J. S., Setubal, J. C., Cunha Neto, E., et al. (2023). Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display. Plos Neglected Tropical Diseases, 17( 1), 1-20 art. e0011019. doi:10.1371/journal.pntd.0011019 -
NLM
Carnero LAR, Kuramoto A, Oliveira LC de, Monteiro JS, Setubal JC, Cunha Neto E, Sabino EC, Giordano RJ. Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display [Internet]. Plos Neglected Tropical Diseases. 2023 ; 17( 1): 1-20 art. e0011019.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1371/journal.pntd.0011019 -
Vancouver
Carnero LAR, Kuramoto A, Oliveira LC de, Monteiro JS, Setubal JC, Cunha Neto E, Sabino EC, Giordano RJ. Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display [Internet]. Plos Neglected Tropical Diseases. 2023 ; 17( 1): 1-20 art. e0011019.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1371/journal.pntd.0011019 - Targeting transcription factors for antiangiogenic therapy
- Recognition of Trypanosoma cruzi epitopes by IgG of benznidazole treated Chagas disease patients
- The oxygen-induced retinopathy mouse model for drug discovery in angiogenesis
- A Genome-Wide Association Study Identifies Novel Susceptibility loci in Chronic Chagas Cardiomyopathy
- Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease
- A refined genome phage display methodology delineates the human antibody response in Chagas disease patients
- A transcriptome-based signature of pathological angiogenesis predicts breast cancer patient survival
- A ligand motif enables differential vascular targeting of endothelial junctions between brain and retina
- Protocol for design, construction, and selection of genome phage (gPhage) display libraries
- Genome Wide Association Study (GWAS) of Chagas Cardiomyopathy in Trypanosoma cruzi Seropositive Subjects
Informações sobre o DOI: 10.1371/journal.pntd.0011019 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 3121058.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
